Increasing incidence of drug toxicity and ADR (adverse drug reactions) are stimulating the market demand.
The global pharmacovigilance market is expected to be worth USD 12.48 Billion by 2027, according to a current analysis by Emergen Research. The market for pharmacovigilance is experiencing rapid growth attributed to a rise in application for spontaneous reporting, electronic health record (HER) mining, cohort event monitoring, and intensified adverse drug reaction (ADR) reporting, among others. The pharmacovigilance primarily emphasizes on on ADR (adverse drug reactions) and cases of drug toxicity. According to the statistic released by WHO, about 5.0% of hospitalized patients in the developed nations are admitted into the hospital due to adverse drug reactions, and 6.0% to 10% of in-patients are anticipated to observe a severe adverse reaction for the duration of hospitalization.
Request a sample copy of the report @ https://www.emergenresearch.com/request-sample/81
Key Highlights From The Report
Emergen Research has segmented the global pharmacovigilance on the basis of type, service provider, clinical trial phase, end-users, and region:
Regional Bifurcation:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
Request customization of the report @ https://www.emergenresearch.com/request-for-customization/81
Key Factors influencing market remuneration:
Table of Content
Chapter 1. Methodology & Sources 1.1. Market Definition 1.2. Research Scope 1.3. Methodology 1.4. Research Sources 1.4.1. Primary 1.4.2. Secondary 1.4.3. Paid Sources 1.5. Market Estimation Technique Chapter 2. Executive Summary 2.1. Summary Snapshot, 2019-2027 Chapter 3. Key Insights Chapter 4. Pharmacovigilance Market Segmentation & Impact Analysis 4.1. Pharmacovigilance Market Material Segmentation Analysis 4.2. Industrial Outlook 4.2.1. Market indicators analysis 4.2.2. Market drivers analysis 4.2.2.1. Growing prevalence of adverse drug reactions and toxicity 4.2.2.2. Rise in drug consumption and development rates 4.2.2.3. Growing trend towards outsourcing pharmacovigilance 4.2.3. Market restraints analysis 4.2.3.1. Dearth of skilled professionals 4.3. Technological Insights 4.4. Regulatory Framework 4.5. Porter’s Five Forces Analysis 4.6. Competitive Metric Space Analysis 4.7. Price trend Analysis 4.8. Covid-19 Impact Analysis
Chapter 5. Pharmacovigilance Market By Type Insights & Trends, Revenue (USD Million) 5.1. Type Dynamics & Market Share, 2019 & 2027 5.1.1. Spontaneous Reporting 5.1.2. Intensified Adverse Drug Reaction (ADR) Reporting 5.1.3. Targeted Spontaneous Reporting 5.1.4. Cohort Event Monitoring 5.1.5. Electronic Health Record (EHR) Mining
CONTINUED…!!
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/pharmacovigilance-market
Thank you for reading our report. To know more about the report, please connect with us, and our team will ensure the report is customized to meet your requirements.
Media ContactCompany Name: Emergen ResearchContact Person: Eric LeeEmail: Send EmailPhone: +1 (604) 757-9756Address:14671 110 Avenue Surrey, British Columbia, V3R2A9City: SurreyState: British ColumbiaCountry: CanadaWebsite: https://www.emergenresearch.com/industry-report/pharmacovigilance-market